Critical Reviews in Oncology Hematology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Fertility management for malignant ovarian germ cell tumors patients
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 14, 2017 Category: Cancer & Oncology Authors: Chiara Di Tucci, Assunta Casorelli, Elisa Morrocchi, Innocenza Palaia, Ludovico Muzii, Pierluigi Benedetti Panici Tags: Review Source Type: research

Ovarian sex-cord stromal tumours and small cell tumours: pathological, genetic and management aspects
Non-epithelial ovarian cancers (NEOC) constitute a group of uncommon malignancies and their treatment is still a challenging task. Collectively, these tumours account for about 10% of all ovarian cancers and occur in all age groups from childhood to old-age. They include malignancies of germ cell origin, sex cord-stromal cell origin, and a variety of extremely rare ovarian cancers, such as small-cell carcinomas and sarcomas. Each of these classifications encompasses multiple histologic subtypes. (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 14, 2017 Category: Cancer & Oncology Authors: Stergios Boussios, Michelle Moschetta, George Zarkavelis, Alexandra Papadaki, Aristides Kefas, Konstantina Tatsi Source Type: research

Patterns and drivers of health care use in long-term childhood cancer survivors: A systematic review
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 13, 2017 Category: Cancer & Oncology Authors: J. Van Breeschoten, R. De Abreu Lourenco, C. Signorelli, M. Haas, R.J. Cohn, C.E. Wakefield, J.E. Fardell Tags: Review Source Type: research

Emerging roles for long noncoding RNAs in B-cell development and malignancy
Long noncoding (lnc)RNAs have emerged as essential mediators of cellular biology, differentiation and malignant transformation. LncRNAs have a broad range of possible functions at the transcriptional, posttranscriptional and protein level and their aberrant expression significantly contributes to the hallmarks of cancer cell biology. In addition, their high tissue- and cell-type specificity makes lncRNAs especially interesting as biomarkers, prognostic factors or specific therapeutic targets. Here, we review current knowledge on lncRNA expression changes during normal B-cell development, indicating essential functions in t...
Source: Critical Reviews in Oncology Hematology - October 13, 2017 Category: Cancer & Oncology Authors: M. Winkle, J.L. Kluiver, Diepstra Arjan, A. van den Berg Source Type: research

Erratum to “Cancer-related Fatigue in Adolescents and Young Adults: A Systematic Review of the Literature” [Crit. Rev. Oncol. Hematol. 118 (2017) 63–69]
The publisher regrets that an incomplete version of Table 3 was published. The full version of Table 3 is show below. (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 12, 2017 Category: Cancer & Oncology Authors: E. Nowe, Y. St öbel-Richter, A. Sender, K. Leuteritz, M. Friedrich, K. Geue Tags: Erratum Source Type: research

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy
Manipulating an individual ’s immune system through immune checkpoint blockade is revolutionizing the paradigms of cancer treatment. Peculiar patterns and kinetics of response have been observed with these new drugs, rendering the assessment of tumor burden particularly challenging in cancer immunotherapy. The mechanisms of action for immune checkpoint blockade, based upon engagement of the adaptive immune system, can generate unusual response patterns, including pseudoprogression, hyperprogression, atypical and delayed responses. (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 10, 2017 Category: Cancer & Oncology Authors: Cinzia Solinas, Michele Porcu, Zuzana Hlavata, Pushpamali De Silva, Marco Puzzoni, Karen Willard-Gallo, Mario Scartozzi, Luca Saba Tags: Review article Source Type: research

Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 8, 2017 Category: Cancer & Oncology Authors: Martin C. M üller, Francisco Cervantes, Henrik Hjorth-Hansen, Jeroen J.W.M. Janssen, Dragana Milojkovic, Delphine Rea, Gianantonio Rosti Source Type: research

MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 7, 2017 Category: Cancer & Oncology Authors: Bhavesh K. Ahir, Howard Ozer, Herbert H. Engelhard, Sajani S. Lakka Source Type: research

Advances in the Management of HER2-Positive Early Breast Cancer
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 5, 2017 Category: Cancer & Oncology Authors: Jos é Baselga, Robert E. Coleman, Javier Cortés, Wolfgang Janni Source Type: research

TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups —A meta-analysis of aggregate data
Gliomas are common brain tumors in both adults and children (Louis et al., 2016). For decades, the classification and the standard clinical approach to gliomas have been largely based on the histological features of these tumors (Louis et al., 2016). However, a wide range of clinical heterogeneities have been observed among tumors within the same histologic type (Eckel-Passow et al., 2015). These inconsistencies in the clinical course and outcome of gliomas within the same histologic type have been one of the major challenges in the clinical practice of neuro-oncology (Chan et al., 2015b). (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 3, 2017 Category: Cancer & Oncology Authors: Huy Gia Vuong, Ahmed M.A. Altibi, Uyen N.P. Duong, Hanh T.T. Ngo, Thong Quang Pham, Aden Ka-Yin Chan, Chul-Kee Park, Kar-Ming Fung, Lewis Hassell Source Type: research

Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - October 3, 2017 Category: Cancer & Oncology Authors: Jing Li, Jian Gu Source Type: research

Corrigendum to “The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity” [Crit. Rev. Oncol./Hematol. 116 (2017) 82–88]
The authors regret that the names and surnames did not appear in the correct order. These should appear as: (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - September 27, 2017 Category: Cancer & Oncology Authors: Paolo Bossi, Maria Cossu Rocca, Renzo Corv ò, Roberta Depenni, Vittorio Guardamagna, Franco Marinangeli, Francesco Miccichè, Fabio Trippa Tags: Corrigendum Source Type: research

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: has it yet become state-of-the-art?
Lung cancer is the most common cause of cancer death globally (Ferlay et al., 2015). Currently, non-small cell lung cancer accounts for more than 80% of all lung cancers, of which the vast majority presents with advanced disease stages and 30 –35% has locally-advanced disease (LA-NSCLC) at diagnosis. Choosing the optimal treatment for these patients is difficult because of the large heterogeneity in disease extend and pathology, as well as in co-morbidity and general condition of each individual patient (Stinchcombe and Socinski, 2009) . (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - September 27, 2017 Category: Cancer & Oncology Authors: Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, Yolande Lievens Tags: Oncology reviews Source Type: research

The molecular genetics of chemotherapy –induced peripheral neuropathy: A systematic review and meta-analysis
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - September 25, 2017 Category: Cancer & Oncology Authors: J. Cliff, A.L. Jorgensen, R. Lord, F. Azam, L. Cossar, D.F. Carr, M. Pirmohamed Tags: Review Source Type: research

Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - September 21, 2017 Category: Cancer & Oncology Authors: Joseph M. Sanfrancesco, Liang Cheng Source Type: research